Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen

Annals of Oncology

Volumn 22, Issue 3, 2011, Pages 671-680

  Picardi, M ^a   Soricelli, A ^b   Grimaldi, F ^a   Nicolai, E ^b   Gallamini, A ^c   Pane, F ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS SDN   (Italy)

^c S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

FDG PET contrast enhanced CT; Hodgkin's lymphoma

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; EPIRUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; IOPROMIDE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; CYCLOPHOSPHAMIDE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; ERYTHROCYTE SEDIMENTATION RATE; EVENT FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; INFECTION; LIVER EXAMINATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OCCULT CANCER; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RISK FACTOR; SPLEEN EXAMINATION; ADOLESCENT; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DRUG EFFECT; KAPLAN MEIER METHOD; LIVER; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; RADIATION EXPOSURE; RECURRENT DISEASE; SCINTISCANNING; SPLEEN; DIAGNOSTIC IMAGING; DIAPHRAGM; FOLLOW UP; IMAGE ANALYSIS; LIVER METASTASIS; METASTASIS; SPLEEN METASTASIS; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; COMBINED MODALITY THERAPY; CONTRAST MEDIA; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; EPIRUBICIN; ETOPOSIDE; FEMALE; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDNISONE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECURRENCE; SPLEEN; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79952015764     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq403     Document Type: Article

References (30)

1. Mauch P, Larson D, Osteen R, et al. Prognostic factors for positive surgical staging in patients with Hodgkin's lymphoma. J Clin Oncol 1990; 8: 257-265.
2. Carde P, Hagenbeek A, Hayat M, et al. Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol 1993; 11: 2258-2272.
3. Rueffer U, Sieber M, Stemberg M, et al. Spleen involvement in Hodgkin's lymphoma: assessment and risk profile. Ann Hematol 2003; 82: 390-396.
4. Diehl V, Stein H, Hummel M, et al. Hodgkin's lymphoma: biology and treatment strategies for primary, refractory, and relapsed disease. In American Society of Hematology Education Program Book. Washington, DC: 2003; 225-247.
5. Horning SJ, Hoppe RT, Breslin S, et al. Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial. J Clin Oncol 2002; 20: 630-637.
6. Glatstein E, Guernsey JM, Rosenberg SA, Kaplan HS. The value of laparotomy and splenectomy in the staging of Hodgkin's disease. Cancer 1969; 24: 709-718.
7. Krikorian JG, Portlock CS, Mauch PM. Hodgkin's disease presenting below the diaphragm: a review. J Clin Oncol 1986; 4: 1551-1562.
8. Leibenhaut MH, Hoppe RT, Varghese A, Rosenberg SA. Sub-diaphragmatic Hodgkin's disease: laparotomy and treatment results in 49 patients. J Clin Oncol 1987; 5: 1050-1055.
9. Pittman CE, Buss DH, Sterchi JM. Detection of liver involvement in Hodgkin's disease. J Surg Oncol 1988; 38: 265-266.
10. Vinnicombe SJ, Reznek RH. Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging 2003; 30(Suppl 1): S42-S55.
11. Jerusalem G, Beguin Y, Fassotte MF. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica 2001; 86: 266-273.
12. Hutchings M, Loft A, Hansen M, et al. Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 2006; 91: 482-489.
13. Munker R, Stengel A, Stabler A, et al. Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease. Verification by laparotomy in 100 cases. Cancer 1995; 76: 1460-1466.
14. de Jong PA, Quarles van Ufford MH, Baarslag HJ, et al. CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. AJR AM J Roentgenol 2009; 192: 745-753.
15. Picardi M, Soricelli A, Pane F, et al. Contrast-enhanced harmonic compound US of the spleen to increase staging accuracy in patients with Hodgkin lymphoma: a prospective study. Radiology 2009; 251: 574-582.
16. Rodriguez-Vigil B, Gomez-Leon N, Pinilla I, et al. PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT. J Nucl Med 2006; 47: 1643-1648.
17. Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood 2007; 110: 3507-3516.
18. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25: 571-578.
19. Pfannenberg AC, Aschoff P, Brechtel K, et al. Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging. Br J Radiol 2007; 80: 437-445.
20. Schaefer NG, Hany TF, Taverna C, et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG-PET and CT at staging and restaging-do we need contrast-enhanced CT? Radiology 2004; 232: 823-829.
21. Harris NL, Jaffe ES, Diebold J, et al. Lymphoma classification: from controversy to consensus-the REAL and WHO classification of lymphoid neoplasms. Ann Oncol 2000; 11: 3-10.
22. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31: 1860-1861.
23. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7: 1630-1636.
24. Picardi M, De Renzo A, Pane F, et al. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. Leuk Lymphoma 2007; 48: 1721-1727.
25. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non Hodgkin's lymphomas. J Clin Oncol 1999; 17: 1244-1253.
26. Antoch G, Saoudi N, Kuehl H, et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004; 22: 4357-4368.
27. Berthelsen AK, Holm S, Loft A, et al. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 2005; 32: 1167-1175.
28. Beyer T, Antoch G, Blodgett T, et al. Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging 2003; 30: 588-596.
29. von Herbay A, Barreiros AP, Ignee A, et al. Contrast-enhanced ultrasonography with Sono Vue: differentiation between benign and malignant lesions of the spleen. J Ultrasound Med 2009; 28: 421-434.
30. Brusamolino E, Bacigalupo A, Barosi G, et al. Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up. Haematologica 2009; 94: 550-565.